Drug intelligence / Profile preview

Tie2-Fc

Development stage
Preclinical
Lead developer
Gyeongsang National University
Modality
Fc-Fusion Proteins → Carrier/Scaffold Proteins → Recombinant Proteins and Enzymes
Administration
Intraperitoneal
01

Overview

Tie2-Fc is a recombinant chimeric decoy receptor designed to inhibit the angiopoietin/Tie2 signaling pathway. It consists of the extracellular domain of the Tie2 (tyrosine kinase with immunoglobulin and epidermal growth factor homology domain 2) receptor fused to the Fc region of a human immunoglobulin (IgG). Tie2-Fc acts as a molecular trap by binding to and sequestering circulating angiopoietins, including Ang-1, Ang-2, and Ang-4, thereby preventing them from interacting with the endogenous Tie2 receptors located on the surface of endothelial cells. This blockade suppresses pathological angiogenesis, vascular remodeling, and associated inflammatory processes. In preclinical research, Tie2-Fc has been utilized to study and treat conditions characterized by abnormal vessel growth and inflammation, such as rheumatoid arthritis and various solid tumors, where it helps reduce synovial inflammation, macrophage infiltration, and bone destruction.

Other names
Tie2-Fc fusion proteinTie-2-Fc fusion proteinTie 2-Fc fusion proteinTie2 decoy receptorTie-2 decoy receptorTie 2 decoy receptorSoluble Tie2-Fc
02

Targets

ANGPT4 (Angiopoietin-4)ANGPT1 (Angiopoietin-1)ANGPT2 (Angiopoietin-2)

Beyond the preview

Go deeper on Tie2-Fc.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Tie2-Fc.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call